Eric Jacobsen, MD
Dana-Farber Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Eric Jacobsen, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:53 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06692452 · Tazemetostat Plus CHOP in 1L T-cell LymphomaEric Jacobsen, MD · withdrawn · Lymphoma, Peripheral T Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma · principal investigator
- Ph2NCT03316573 · Pembrolizumab in Neoplasms or LymphomasDana-Farber Cancer Institute · suspended · Lymphoma, Histiocytic Sarcoma, Follicular Dendritic Cell Sarcoma · principal investigator
- Ph2NCT02523040 · Lenalidomide for Adult Histiocyte DisordersDana-Farber Cancer Institute · active not recruiting · Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) · principal investigator
- Ph2NCT00684411 · Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's LymphomaDana-Farber Cancer Institute · completed · T Cell Non-Hodgkin Lymphoma · principal investigator
- N/ANCT00487513 · Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical TrialsDana-Farber Cancer Institute · completed · Non-Hodgkin's Lymphoma · principal investigator
- Ph1NCT00487305 · Vaccination for the Treatment of Previously Untreated or Relapsed Follicular LymphomaDana-Farber Cancer Institute · completed · Follicular Lymphoma · principal investigator
- N/ANCT00355407 · Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell TransplantationDana-Farber Cancer Institute · completed · Hematologic Malignancies · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.